Brawn Biotech Past Earnings Performance
Past criteria checks 0/6
Brawn Biotech's earnings have been declining at an average annual rate of -39.2%, while the Healthcare industry saw earnings growing at 23.2% annually. Revenues have been declining at an average rate of 30.3% per year.
Key information
-39.2%
Earnings growth rate
-38.5%
EPS growth rate
| Healthcare Industry Growth | 29.4% |
| Revenue growth rate | -30.3% |
| Return on equity | -36.0% |
| Net Margin | -11.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Brawn Biotech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 137 | -15 | 17 | 0 |
| 30 Jun 24 | 134 | -19 | 15 | 0 |
| 31 Mar 24 | 165 | -12 | 17 | 0 |
| 31 Dec 23 | 181 | -15 | 18 | 0 |
| 30 Sep 23 | 213 | -12 | 16 | 0 |
| 30 Jun 23 | 261 | -12 | 16 | 0 |
| 31 Mar 23 | 222 | -9 | 16 | 0 |
| 31 Dec 22 | 203 | 4 | 19 | 0 |
| 30 Sep 22 | 166 | -12 | 18 | 0 |
| 30 Jun 22 | 109 | -13 | 16 | 0 |
| 31 Mar 22 | 86 | -16 | 22 | 0 |
| 31 Dec 21 | 88 | -29 | 23 | 0 |
| 30 Sep 21 | 210 | -11 | 26 | 0 |
| 30 Jun 21 | 287 | -6 | 25 | 0 |
| 31 Mar 21 | 350 | -6 | 26 | 0 |
| 31 Dec 20 | 386 | -3 | 29 | 0 |
| 30 Sep 20 | 370 | -10 | 40 | 0 |
| 30 Jun 20 | 392 | -2 | 30 | 0 |
| 31 Mar 20 | 496 | 6 | 34 | 0 |
| 31 Dec 19 | 584 | 12 | 36 | 0 |
| 30 Sep 19 | 664 | 14 | 35 | 0 |
| 30 Jun 19 | 695 | 15 | 35 | 0 |
| 31 Mar 19 | 652 | 13 | 36 | 0 |
| 31 Dec 18 | 662 | 12 | 38 | 0 |
| 30 Sep 18 | 618 | 13 | 38 | 0 |
| 30 Jun 18 | 584 | 15 | 30 | 0 |
| 31 Mar 18 | 558 | 13 | 34 | 0 |
| 31 Dec 17 | 565 | 14 | 58 | 0 |
| 30 Sep 17 | 558 | 12 | 53 | 0 |
| 30 Jun 17 | 567 | 13 | 52 | 0 |
| 31 Mar 17 | 605 | 14 | 51 | 0 |
| 31 Dec 16 | 561 | 10 | 25 | 0 |
| 30 Sep 16 | 525 | 10 | 26 | 0 |
| 30 Jun 16 | 519 | 7 | 20 | 0 |
| 31 Mar 16 | 469 | 9 | 24 | 0 |
| 31 Dec 15 | 429 | 12 | 29 | 0 |
| 30 Sep 15 | 418 | 10 | 16 | 0 |
| 30 Jun 15 | 408 | 7 | 19 | 0 |
| 31 Mar 15 | 387 | 3 | 18 | 0 |
| 31 Dec 14 | 407 | 0 | 38 | 0 |
| 30 Sep 14 | 381 | -3 | 40 | 0 |
| 30 Jun 14 | 373 | -4 | 44 | 0 |
| 31 Mar 14 | 378 | 1 | 49 | 0 |
| 31 Dec 13 | 340 | 4 | 35 | 0 |
Quality Earnings: 530207 is currently unprofitable.
Growing Profit Margin: 530207 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 530207 is unprofitable, and losses have increased over the past 5 years at a rate of 39.2% per year.
Accelerating Growth: Unable to compare 530207's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 530207 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (29.6%).
Return on Equity
High ROE: 530207 has a negative Return on Equity (-36.02%), as it is currently unprofitable.